Fig. 1From: The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosisPercent change in mean total IgE = Immunoglobulin E after ETI = Elexacaftor/Tezacaftor/Ivacaftor initiation, with 95% confidence intervals computed from the multivariable mixed-effect model. Each point represents the percent change in 12-month mean IgE of a single patient after starting ETIBack to article page